Piotr Kuna

11PUBLICATIONS
310CO-AUTHORS
Medical biotechnology not elsewhere classifiedAllergyBiologically active moleculesRespiratory diseasesOptical technology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 05, 2026
Author Correction: Benralizumab versus placebo for hypereosinophilic syndrome: a randomized, placebo-controlled phase 3 trial.

|Mar 31, 2026
Benralizumab versus placebo for hypereosinophilic syndrome: a randomized, placebo-controlled phase 3 trial.

Princess U Ogbogu, Florence Roufosse, Praveen Akuthota

|May 14, 2024
Bilastine for the treatment of allergic rhinoconjunctivitis and urticaria: results from an international Delphi study.

Giorgio Walter Canonica, Piotr Kuna, Marcus Maurer

|May 03, 2024
Exploring Definitions and Predictors of Severe Asthma Clinical Remission after Biologic Treatment in Adults.

Luis Perez-de-Llano, Ghislaine Scelo, Trung N Tran

|May 16, 2023
An international Delphi study on the burden of allergic rhinoconjunctivitis and urticaria and the role of bilastine among current treatment options.

M K Church, G W Canonica, P Kuna

|Mar 13, 2023
Safety and Tolerability of Bilastine 0.6% Ophthalmic Solution: An 8-Weeks Phase III Study.

Piotr Kuna, Marek Jutel, Grazyna Pulka

Pageof 2

Frequent Collaborators

5 joint publications

Giorgio Walter Canonica

4 joint publications

Nikolaus Papadopoulos

3 joint publications

Désirée Erlinda Larenas-Linnemann

3 joint publications

Marcus Maurer